A unique range of over 3000 novel substituted fluoro aromatic compounds functionalised with a variety of synthetically useful reactive groups.
The European Commission has ruled that UCB’s anti-epileptic Vimpat can be used in children.
Read More >
Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >